SAFE established a set of business processes and best practices that leverage PKI for digital signatures. Using a digital signature solution from Arcot, AstraZeneca announced that it was the first pharmaceutical company to present a completely electronic and digitally signed submission to the FDA.
Arcot's Doc Vaidhyanathan comments on the return of PKI.
February 20, 2007 - United Press International
AstraZeneca to Digitally Sign FDA Apps
Using Arcot digital signature technology, U.S. drug giant AstraZeneca has become the first company to submit completely digital applications to the FDA.